Kestra Medical plans sale of 5,887 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Kestra Medical Technologies, Ltd. filed to permit the sale of up to 5,887 shares of common stock through Merrill Lynch on or about July 30, 2026 on NASDAQ. These shares relate to the vesting of performance share unit awards on July 17, 2026, originally granted as part of issuer equity compensation.
Key Figures
Key Terms
equity compensation financial
Common Stock financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stock sale is Kestra Medical Technologies (KMTS) registering?
Which broker and market are involved in the Kestra Medical (KMTS) planned sale?
Does the Kestra Medical (KMTS) Form 144 show any other sales in the past 3 months?
AI-generated analysis. How Rhea-AI works. Not financial advice.